Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity

Schmohl, Jorg U.; Felices, Martin; Oh, Felix; Lenvik, Alexander J.; Lebeau, Aaron M.; Panyam, Jayanth; Miller, Jeffrey S.; Vallera, Daniel A.

dc.contributor.author	Schmohl, Jörg Uwe
dc.date.accessioned	2019-04-23T12:19:21Z
dc.date.available	2019-04-23T12:19:21Z
dc.date.issued	2017
dc.identifier.issn	2005-9256
dc.identifier.uri	http://hdl.handle.net/10900/87987
dc.language.iso	en	de_DE
dc.publisher	Korean Cancer Association	de_DE
dc.relation.uri	http://dx.doi.org/10.4143/crt.2016.491	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190131163842_00905
utue.publikation.seiten	1140-1152	de_DE
utue.personen.roh	Schmohl, Jorg U.
utue.personen.roh	Felices, Martin
utue.personen.roh	Oh, Felix
utue.personen.roh	Lenvik, Alexander J.
utue.personen.roh	Lebeau, Aaron M.
utue.personen.roh	Panyam, Jayanth
utue.personen.roh	Miller, Jeffrey S.
utue.personen.roh	Vallera, Daniel A.
dcterms.isPartOf.ZSTitelID	Cancer Research and Treatment	de_DE
dcterms.isPartOf.ZS-Issue	4	de_DE
dcterms.isPartOf.ZS-Volume	49	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE